Ponesimod is a selective sphingosine-1-phosphate receptor 1 (S1P1) modulator used for the treatment of relapsing forms of multiple sclerosis. This category provides comprehensive reference standards, including… Read more





Ponesimod is a selective sphingosine-1-phosphate receptor 1 (S1P1) modulator used for the treatment of relapsing forms of multiple sclerosis. This category provides comprehensive reference standards, including the active pharmaceutical ingredient, to support rigorous quality control and analytical testing. Pharmaceutical laboratories utilize these materials, such as related degradation products, process-related impurities, and stable isotope-labelled compounds, for accurate impurity profiling and method validation. By incorporating these well-characterized standards—including specific isomers and structurally related analogs—researchers can effectively monitor potency, stability, and safety throughout the drug development lifecycle. These materials are essential for identifying and quantifying potential impurities arising from hydrolysis or oxidation, ensuring compliance with regulatory standards for structural characterization and analytical method development.